Trust Company of Toledo’s Charles River Laboratories CRL Stock Holding History

Trust Company of Toledo’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.5K	Buy	+117	New	+$20.8K	﹤0.01%	567

Other funds holding CRL

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

LKIM

Lawson Kroeker Investment Management Omaha, Nebraska $361M AUM 22.26% 1-Year Est. Return

Trust Company of Toledo's CRL Position: Q2 2026 in Review

Trust Company of Toledo opened a new position in Charles River Laboratories (CRL) in Q2 2026: 117 shares worth $26.5K. The stake represents ﹤0.01% of the portfolio and ranks #567 among its holdings.

161 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Trust Company of Toledo held 117 shares of Charles River Laboratories worth $26.5K as of Q2 2026.
Charles River Laboratories was a new Trust Company of Toledo position in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #567 holding.
161 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.